Effect of the multimodal antidepressant LU AA21004 on rat hippocampal plasticity and recognition

被引：0
|
作者：
Haddjeri, N. [1 ]
Etievant, A. [1 ]
Pehrson, A. [2 ]
Sanchez, C. [2 ]
Betry, C. [1 ]
机构：
[1] Univ Lyon, Lyon, France
[2] Lundbeck Res USA, Paramus, NJ USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-09-023
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [31] EFFECT OF FORMULATION AND FOOD ON THE PHARMACOKINETICS OF LU AA21004 IN HEALTHY SUBJECTS.
    Mayer, M.
    Xie, J.
    Serenko, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S69 - S70
  • [32] Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder
    Baldwin, David S.
    Loft, Henrik
    Florea, Ioana
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (04) : 197 - 207
  • [33] LACK OF EFFECT OF MULTIPLE DOSES OF LU AA21004 ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF ASPIRIN.
    Wang, Y.
    Zhang, W.
    Agyemang, A.
    Ross, G.
    Astruc, B.
    Nomikos, G.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1082 - 1082
  • [34] Discovery of Lu AA21004: A novel compound for the treatment of mood disorders
    Bang-Andersen, Benny
    Ruhland, Thomas
    Smith, Garrick
    Jorgensen, Morten
    Bjornholm, Berith
    Andersen, Kim
    Moltzen, Ejner K.
    Mork, Arne
    Brennum, Lise T.
    Jensen, Klaus G.
    Stensbol, Tine B.
    Hogg, Sandra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [35] Steady-State Levels of the Antidepressant Lu AA21004 in Plasma, Brain and CSF, and 5-HT Target Engagement in the Rat
    Pehrson, Alan L.
    Chandrasena, Gamini
    Carnerup, Martin
    Jorgensen, Laerke B.
    Ebert, Bjarke
    Sanchez, Connie
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 186S - 187S
  • [36] The novel antidepressant Lu AA21004 exerts its multi-modal activity through serotonergic targets
    Sanchez, C.
    Nielsen, S. M.
    Pehrson, A.
    Zhong, H.
    Lassen, A. B.
    Bisulco, S.
    Mork, A.
    Wegener, G.
    Stensbol, T. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S404 - S405
  • [37] Lu AA21004, a novel antidepressant, modulates neurotransmitter levels and theta oscillations, and exerts pro-cognitive effects in rats
    Arbell, M.
    Diaz, M. C.
    Morales, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S407 - S408
  • [38] Preclinical characterisation of the novel antidepressant Lu AA21004: key role for the 5-HT3 receptors blockade
    Haddjeri, N.
    Etievant, A.
    Ebert, B.
    Sanchez, C.
    Betry, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S376 - S377
  • [39] The Clinical Pharmacokinetics of Lu AA21004 and its Major Metabolite in Healthy Young Volunteers
    Areberg, Johan
    Sogaard, Birgitte
    Hojer, Astrid-Maria
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (03) : 198 - 205
  • [40] A randomised, double-blind, placebo-controlled, active-referenced study of the multimodal antidepressant Lu AA21004 in the treatment of elderly depressed patients
    Katona, C.
    Hansen, T.
    Olsen, C. K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S258 - S259
12345